Cover Image
市場調查報告書

輕鬱症:全球臨床實驗檢討

Dysthymia Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 307771
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
輕鬱症:全球臨床實驗檢討 Dysthymia Global Clinical Trials Review, H2, 2017
出版日期: 2017年07月31日 內容資訊: 英文 50 Pages
簡介

本報告提供全球主要地區的輕鬱症治療藥臨床實驗數和被實驗人數,各階段趨勢,再彙整主要企業和機關,臨床實驗簡介等。

簡介

  • 輕鬱症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,輕鬱症臨床實驗數量所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,輕鬱症臨床實驗數量所佔的比例

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗參與的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sanofi
    • COLUMBIA NORTHWEST PHARMACEUTICALS
    • Auckland UniServices Limited
    • AB Science
  • 有代表性的研究機關·醫院臨床實驗概要
    • New York State Psychiatric Institute
    • Centre for Addiction and Mental Health
    • University of Washington
    • University Hospital Freiburg
    • St. Luke's-Roosevelt Hospital Center
    • University of Barcelona
    • University of California, Los Angeles
    • The Sheba Medical Center
    • Sunnybrook Health Sciences Centre
    • Oregon Health & Science University

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4417CTIDB

GlobalData's clinical trial report, "Dysthymia Global Clinical Trials Review, H2, 2017" provides an overview of Dysthymia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysthymia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Dysthymia to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Dysthymia to Central Nervous System Clinical Trials 17
  • Clinical Trials by Phase 18
  • In Progress Trials by Phase 19
  • Clinical Trials by Trial Status 20
  • Clinical Trials by End Point Status 21
  • Subjects Recruited Over a Period of Time 22
  • Clinical Trials by Sponsor Type 23
  • Prominent Sponsors 24
  • Top Companies Participating in Dysthymia Therapeutics Clinical Trials 25
  • Prominent Drugs 26
  • Clinical Trial Profile Snapshots 27

Appendix 48

  • Abbreviations 48
  • Definitions 48
  • Research Methodology 49
  • Secondary Research 49
  • About GlobalData 50
  • Contact Us 50
  • Source 50

List of Tables

List of Tables

  • Dysthymia Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Dysthymia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Dysthymia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Dysthymia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Dysthymia Therapeutics Clinical Trials, Europe, Top Countries, 2017* 11
  • Dysthymia Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Dysthymia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Dysthymia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
  • Dysthymia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Dysthymia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Dysthymia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
  • Dysthymia Therapeutics, Global, Clinical Trials by Phase, 2017* 18
  • Dysthymia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 19
  • Dysthymia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
  • Dysthymia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Dysthymia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Dysthymia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
  • Dysthymia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
  • Dysthymia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
  • Dysthymia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26

List of Figures

List of Figures

  • Dysthymia Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Dysthymia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Dysthymia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Dysthymia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
  • Dysthymia Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 11
  • Dysthymia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Proportion of Dysthymia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
  • Dysthymia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Dysthymia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Dysthymia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
  • Dysthymia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
  • Dysthymia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 19
  • Dysthymia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
  • Dysthymia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Dysthymia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Dysthymia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
  • Dysthymia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
  • Dysthymia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
  • Dysthymia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26
  • GlobalData Methodology 49
Back to Top